29 | Immune Checkpoint InhibitorsIBA
05/2024
-
01/2019 |
26 | Biomarkers (Surrogate Marker)IBA
02/2024
-
12/2010 |
22 | lenvatinibIBA
04/2024
-
01/2019 |
19 | Proteins (Proteins, Gene)FDA Link
12/2023
-
04/2002 |
8 | RNA (Ribonucleic Acid)IBA
12/2023
-
01/2019 |
8 | MicroRNAs (MicroRNA)IBA
01/2022
-
12/2010 |
7 | AntigensIBA
01/2022
-
01/2006 |
5 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
04/2024
-
01/2021 |
5 | B7-H1 AntigenIBA
02/2024
-
07/2018 |
5 | Long Noncoding RNAIBA
01/2022
-
01/2014 |
5 | DNA (Deoxyribonucleic Acid)IBA
01/2021
-
01/2017 |
4 | Tumor Biomarkers (Tumor Markers)IBA
11/2023
-
09/2010 |
4 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2023
-
10/2020 |
4 | 68Ga-FAPIIBA
10/2023
-
01/2021 |
4 | Bevacizumab (Avastin)FDA Link
01/2023
-
01/2020 |
4 | Indicators and Reagents (Reagents)IBA
02/2022
-
05/2014 |
4 | CarbohydratesIBA
01/2022
-
10/2020 |
4 | AlbuminsIBA
01/2021
-
01/2016 |
4 | Peptides (Polypeptides)IBA
01/2021
-
01/2005 |
3 | CollagenIBA
03/2024
-
01/2023 |
3 | GemcitabineFDA Link
02/2024
-
01/2019 |
3 | LipidsIBA
01/2023
-
10/2019 |
3 | Small Interfering RNA (siRNA)IBA
01/2023
-
01/2016 |
3 | AntibodiesIBA
01/2023
-
08/2021 |
3 | atezolizumabIBA
10/2022
-
01/2020 |
3 | Sorafenib (BAY 43-9006)FDA Link
01/2022
-
01/2019 |
3 | Nucleic AcidsIBA
12/2021
-
01/2017 |
3 | Transaminases (Aminotransferases)IBA
08/2021
-
08/2020 |
3 | Cell-Free Nucleic AcidsIBA
01/2021
-
01/2019 |
3 | Messenger RNA (mRNA)IBA
05/2020
-
04/2002 |
2 | LigandsIBA
04/2024
-
12/2020 |
2 | HydrogelsIBA
10/2023
-
07/2006 |
2 | Therapeutic UsesIBA
01/2023
-
10/2020 |
2 | toripalimabIBA
01/2023
-
01/2023 |
2 | ApolipoproteinsIBA
01/2023
-
10/2020 |
2 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2023
-
01/2022 |
2 | Hemoglobins (Hemoglobin)IBA
12/2022
-
02/2018 |
2 | EnzymesIBA
11/2022
-
01/2016 |
2 | Tyrosine Kinase InhibitorsIBA
10/2022
-
08/2021 |
2 | BilirubinIBA
08/2022
-
04/2015 |
2 | N-methyladenosineIBA
01/2022
-
05/2020 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2022
-
01/2020 |
2 | Proton Pump InhibitorsIBA
01/2022
-
04/2017 |
2 | Cisplatin (Platino)FDA LinkGeneric
12/2021
-
01/2019 |
2 | Programmed Cell Death 1 ReceptorIBA
12/2021
-
12/2020 |
2 | apatinibIBA
01/2021
-
01/2021 |
2 | IntegrinsIBA
01/2021
-
01/2016 |
2 | pembrolizumabIBA
12/2020
-
08/2020 |
2 | alpha-Fetoproteins (alpha-Fetoprotein)IBA
05/2020
-
12/2010 |